| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
100,490,000 |
| Market
Cap: |
3.75(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$19.98 - $50.8 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Viking Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapies for metabolic and endocrine disorders. Co.'s primary clinical program's drug candidate, VK2809, is an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRss). Co. is also developing VK0214, which is also an orally available, tissue and receptor-subtype selective agonist of TRss for X-linked adrenoleukodystrophy, a rare X-linked, inherited neurological disorder characterized by a breakdown in the protective barriers surrounding brain and nerve cells.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
1,240 |
1,240 |
| Total Buy Value |
$0 |
$0 |
$29,943 |
$29,943 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
111,359 |
146,780 |
445,794 |
1,991,548 |
| Total Sell Value |
$3,932,174 |
$4,916,708 |
$17,698,503 |
$105,117,964 |
| Total People Sold |
4 |
4 |
4 |
7 |
| Total Sell Transactions |
4 |
7 |
10 |
33 |
| End Date |
2025-09-11 |
2025-06-10 |
2024-12-10 |
2023-12-11 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lian Brian |
President & CEO |
• • – |
2025-10-28 |
4 |
S |
$35.01 |
$1,364,923 |
D/D |
(38,989) |
2,419,109 |
|
-10% |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2025-10-28 |
4 |
S |
$35.00 |
$216,492 |
D/D |
(6,185) |
382,467 |
|
-10% |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2025-10-28 |
4 |
S |
$35.00 |
$216,481 |
D/D |
(6,185) |
173,592 |
|
-10% |
|
| Rowland Charles A Jr |
|
– • – |
2025-10-27 |
4 |
S |
$35.57 |
$2,134,278 |
D/D |
(60,000) |
30,000 |
|
-7% |
|
| Rowland Charles A Jr |
|
– • – |
2025-10-27 |
4 |
A |
$4.48 |
$306,640 |
D/D |
60,000 |
90,000 |
|
- |
|
| Lian Brian |
President & CEO |
• • – |
2025-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
70,084 |
2,458,098 |
|
- |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2025-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
11,117 |
388,652 |
|
- |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2025-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
11,117 |
179,777 |
|
- |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2025-07-03 |
4 |
S |
$27.77 |
$118,473 |
D/D |
(4,266) |
377,535 |
|
-34% |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2025-07-03 |
4 |
S |
$27.76 |
$118,428 |
D/D |
(4,266) |
168,660 |
|
-34% |
|
| Lian Brian |
President & CEO |
• • – |
2025-07-03 |
4 |
S |
$27.80 |
$747,633 |
D/D |
(26,889) |
2,388,014 |
|
-34% |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2025-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,667 |
381,801 |
|
- |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2025-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,667 |
172,926 |
|
- |
|
| Lian Brian |
President & CEO |
• • – |
2025-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
48,333 |
2,414,903 |
|
- |
|
| Foehr Matthew W |
|
– • – |
2025-04-11 |
4 |
OE |
$8.00 |
$166,288 |
D/D |
20,786 |
132,036 |
|
- |
|
| Rouan Sarah Kathryn |
|
– • – |
2025-03-31 |
4 |
B |
$24.15 |
$29,943 |
D/D |
1,240 |
1,240 |
0.01 |
57% |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2025-01-06 |
4 |
S |
$42.69 |
$2,150,595 |
D/D |
(50,309) |
165,259 |
|
33% |
|
| Lian Brian |
President & CEO |
• • – |
2025-01-06 |
4 |
S |
$42.68 |
$8,313,601 |
D/D |
(194,490) |
2,366,570 |
|
33% |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2025-01-06 |
4 |
S |
$42.69 |
$2,317,599 |
D/D |
(54,215) |
374,134 |
|
33% |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2025-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
66,200 |
215,568 |
|
- |
|
| Lian Brian |
President & CEO |
• • – |
2025-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
256,133 |
2,561,060 |
|
- |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2025-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
66,200 |
428,349 |
|
- |
|
| Macartney Lawson |
|
– • – |
2024-11-08 |
4 |
S |
$68.67 |
$137,333 |
D/D |
(2,000) |
47,965 |
|
57% |
|
| Macartney Lawson |
|
– • – |
2024-11-08 |
4 |
OE |
$5.80 |
$11,600 |
D/D |
2,000 |
49,965 |
|
- |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2024-10-28 |
4 |
AS |
$74.56 |
$10,089,164 |
D/D |
(131,687) |
149,366 |
|
-64% |
|
197 Records found
|
|
Page 1 of 8 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.70 (1.84%) 
